Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)

被引:120
作者
Fogo, Agnes B. [1 ]
Bostad, Leif [2 ,3 ]
Svarstad, Einar [4 ,5 ]
Cook, William J. [6 ]
Moll, Solange [7 ]
Barbey, Federic [8 ]
Geldenhuys, Laurette [9 ]
West, Michael [10 ]
Ferluga, Dusan [11 ]
Vujkovac, Bojan [12 ]
Howie, Alexander J. [13 ]
Burns, Aine [14 ]
Reeve, Roy [16 ]
Waldek, Stephen [15 ]
Noel, Laure-Helene [17 ]
Gruenfeld, Jean-Pierre [18 ]
Valbuena, Carmen [19 ]
Oliveira, Joao Paulo [20 ]
Mueller, Justus [21 ]
Breunig, Frank [22 ]
Zhang, Xiao [23 ]
Warnock, David G. [24 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[2] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway
[3] Gade Inst, Sect Pathol, Bergen, Norway
[4] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway
[5] Univ Bergen, Inst Med, Bergen, Norway
[6] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[7] Univ Hosp Geneva, Inst Pathol, Geneva, Switzerland
[8] Univ Lausanne Hosp, Ctr Hosp Univ Vaudois, Transplanatat Ctr, Lausanne, Switzerland
[9] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada
[10] Dalhousie Univ, Dept Med, Div Nephrol, Halifax, NS, Canada
[11] Univ Ljubljana, Inst Pathol, Fac Med, Ljubljana, Slovenia
[12] Gen Hosp, Dept Nephrol & Dialysis, Slovenj Gradec, Slovenia
[13] UCL, Sch Med, Royal Free Hosp, Dept Cellular Pathol, London W1N 8AA, England
[14] Royal Free Hampstead NHS Trust, Ctr Nephrol, London, England
[15] Salford Royal Hosp NHS Fdn Trust, Dept Metab Dis, Manchester, Lancs, England
[16] Salford Royal Hosp NHS Fdn Trust, Dept Histopathol, Manchester, Lancs, England
[17] Univ Paris 05, Dept Pathol, Paris, France
[18] Univ Paris 05, Necker Hosp, Dept Nephrol, Paris, France
[19] Hosp Sao Joao, Dept Pathol, Oporto, Portugal
[20] Hosp Sao Joao, Dept Nephrol & Human Genet, Fac Med, Oporto, Portugal
[21] Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany
[22] Univ Wurzburg, Dept Med, Wurzburg, Germany
[23] Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA
[24] Univ Alabama, Dept Med, Birmingham, AL 35294 USA
关键词
chronic kidney disease; Fabry disease; pathology; sclerosis; scoring; ENZYME REPLACEMENT THERAPY; GLOMERULAR-FILTRATION-RATE; ALPHA-GALACTOSIDASE; NATURAL-HISTORY; KIDNEY-FUNCTION; BIOPSY FINDINGS; FEMALES; CLASSIFICATION; INVOLVEMENT; DIAGNOSIS;
D O I
10.1093/ndt/gfp528
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Methods. An international working group of nephrologists from 11 Fabry centres identified adult Fabry patients, and pathologists scored histologic changes on renal biopsies. A standardized scoring system was developed with a modified Delphi technique assessing 59 Fabry nephropathy cases. Each case was scored independently of clinical information by at least three pathologists with an average final score reported. Results. We assessed 35 males (mean age 36.4 years) and 24 females (43.9 years) who mostly had clinically mild Fabry nephropathy. The average serum creatinine was 1.3 mg/dl (114.9 mu mol/l); estimated glomerular filtration rate was 81.7 ml/min/1.73 m(2) and urine protein to creatinine ratio was 1.08 g/g (122.0 mg/mmol). Males had greater podocyte vacuolization on light microscopy (mean score) and glycosphingolipid inclusions on semi-thin sections than females. Males also had significantly more proximal tubule, peritubular capillary and vascular intimal inclusions. Arteriolar hyalinosis was similar, but females had significantly more arterial hyalinosis. Chronic kidney disease stage correlated with arterial and glomerular sclerosis scores. Significant changes, including segmental and global sclerosis, and interstitial fibrosis were seen even in patients with stage 1-2 chronic kidney disease with minimal proteinuria. Conclusions. The development of a standardized scoring system of both disease-specific lesions, i.e. lipid deposition related, and general lesions of progression, i.e. fibrosis and sclerosis, showed a spectrum of histologic appearances even in early clinical stage of Fabry nephropathy. These findings support the role of kidney biopsy in the baseline evaluation of Fabry nephropathy, even with mild clinical disease. The scoring system will be useful for longitudinal assessment of prognosis and responses to therapy for Fabry nephropathy.
引用
收藏
页码:2168 / 2177
页数:10
相关论文
共 37 条
[1]  
Aakre KM, 2009, CLIN NEPHROL, V71, P118
[2]   Renal pathology in Fabry disease [J].
Alroy, J ;
Sabnis, S ;
Kopp, JB .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06) :S134-S138
[3]  
[Anonymous], 2007, AM J KIDNEY DIS
[4]  
BARBEY F, 2008, NDT PLUS, V1, P11
[5]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[6]   Natural history of Fabry renal disease -: Influence of α-galactosidase A activity and genetic mutations on clinical course [J].
Branton, MH ;
Schiffmann, R ;
Sabnis, SG ;
Murray, GJ ;
Quirk, JM ;
Altarescu, G ;
Goldfarb, L ;
Brady, RO ;
Balow, JE ;
Austin, HA ;
Kopp, JB .
MEDICINE, 2002, 81 (02) :122-138
[7]   Pathologic classification of focal segmental glomerulosclerosis [J].
D'Agati, V .
SEMINARS IN NEPHROLOGY, 2003, 23 (02) :117-134
[8]   Natural history of Fabry disease in females in the Fabry outcome survey [J].
Deegan, PB ;
Baehner, AF ;
Romero, MAB ;
Hughes, DA ;
Kampmann, C ;
Beck, M .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (04) :347-352
[9]  
Desnick RobertJ., 2001, The Metabolic and Molecular Bases of Inherited Disease, V8th, P3733
[10]   Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease. [J].
Eng, CM ;
Guffon, N ;
Wilcox, WR ;
Germain, DP ;
Lee, P ;
Waldek, S ;
Caplan, L ;
Linthorst, GE ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :9-16